首页 正文

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2023 Dec;36(1):2199343. doi: 10.1080/14767058.2023.2199343 Q41.72024

Maternal SARS-COV-2 infection and prematurity: the Southern Michigan COVID-19 collaborative

母体SARS-CoV-2感染与早产:密歇根南部COVID-19协作研究 翻译改进

Ray Bahado-Singh  1, Adi L Tarca  2  3  4, Yasmin G Hasbini  5, Robert J Sokol  3, Madhurima Keerthy  6, Gregory Goyert  6, Theodore Jones  7, Lisa Thiel  8, Pooja Green  9, Youssef Youssef  10, Courtney Townsel  11, Shyla Vengalil  12, Paige Paladino  13, Amy Wright  14, Mariam Ayyash  6, Gayathri Vadlamudi  6, Marta Szymanska  1, Sonia Sajja  1, Onur Turkoglu  1, Grace Sterenberg  8, Alexandra R Mangus  11, Micheal Baracy  12, Maria Gibbons  12, Karlee Grace  13, Kaitlyn Houston  13, Jessica Norman  14, Dereje W Gudicha  2  3, Sonia S Hassan  3  5  15; Southern Michigan Regional COVID-19 Collaborative

作者单位 +展开

作者单位

  • 1 Department of Obstetrics and Gynecology, William Beaumont Hospital - Royal Oak, Royal Oak, MI, USA.
  • 2 Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA.
  • 3 Department of Obstetrics and Gynecology, School of Medicine, Wayne State University, Detroit, MI, USA.
  • 4 Department of Computer Science, College of Engineering, Wayne State University, Detroit, MI, USA.
  • 5 Office of Women's Health, Wayne State University, Detroit, MI, USA.
  • 6 Department of Obstetrics and Gynecology, Henry Ford Health System, Detroit, MI, USA.
  • 7 Beaumont Hospital Dearborn, Dearborn, MI, USA.
  • 8 Spectrum Health, Grand Rapids, MI, USA.
  • 9 St Joseph Mercy Health System, Ann Arbor, MI, USA.
  • 10 Hurley Medical Center, Flint, MI, USA.
  • 11 Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA.
  • 12 Ascension St John Hospital, Detroit, MI, USA.
  • 13 Ascension Macomb-Oakland Hospital, Madison Heights, MI, USA.
  • 14 St. Joseph Mercy Oakland, Trinity Health, Pontiac, MI, USA.
  • 15 Department of Physiology, School of Medicine, Wayne State University, Detroit, MI, USA.
  • DOI: 10.1080/14767058.2023.2199343 PMID: 37217448

    摘要 Ai翻译

    Objective: COVID-19 has been reported to increase the risk of prematurity, however, due to the frequent absence of unaffected controls as well as inadequate accounting for confounders in many studies, the question requires further investigation. We sought to determine the impact of COVID-19 disease on preterm birth (PTB) overall, as well as related subcategories such as early prematurity, spontaneous, medically indicated preterm birth, and preterm labor (PTL). We assessed the impact of confounders such as COVID-19 risk factors, a-priori risk factors for PTB, symptomatology, and disease severity on rates of prematurity.

    Methods: This was a retrospective cohort study of pregnant women from March 2020 till October 1st, 2020. The study included patients from 14 obstetric centers in Michigan, USA. Cases were defined as women diagnosed with COVID-19 at any point during their pregnancy. Cases were matched with uninfected women who delivered in the same unit, within 30 d of the delivery of the index case. Outcomes of interest were frequencies of prematurity overall and subcategories of preterm birth (early, spontaneous/medically indicated, preterm labor, and premature preterm rupture of membranes) in cases compared to controls. The impact of modifiers of these outcomes was documented with extensive control for potential confounders. A p value <.05 was used to infer significance.

    Results: The rate of prematurity was 8.9% in controls, 9.4% in asymptomatic cases, 26.5% in symptomatic COVID-19 cases, and 58.8% among cases admitted to the ICU. Gestational age at delivery was noted to decrease with disease severity. Cases were at an increased risk of prematurity overall [adjusted relative risk (aRR) = 1.62 (1.2-2.18)] and of early prematurity (<34 weeks) [aRR = 1.8 (1.02-3.16)] when compared to controls. Medically indicated prematurity related to preeclampsia [aRR = 2.46 (1.47-4.12)] or other indications [aRR = 2.32 (1.12-4.79)], were the primary drivers of overall prematurity risk. Symptomatic cases were at an increased risk of preterm labor [aRR = 1.74 (1.04-2.8)] and spontaneous preterm birth due to premature preterm rupture of membranes [aRR = 2.2(1.05-4.55)] when compared to controls and asymptomatic cases combined. The gestational age at delivery followed a dose-response relation with disease severity, as more severe cases tended to deliver earlier (Wilcoxon p < .05).

    Conclusions: COVID-19 is an independent risk factor for preterm birth. The increased preterm birth rate in COVID-19 was primarily driven by medically indicated delivery, with preeclampsia as the principal risk factor. Symptomatic status and disease severity were significant drivers of preterm birth.

    Keywords: Coronavirus disease 2019 (COVID-19); SARS-CoV-2; preeclampsia; pregnancy; premature labor; preterm birth; preterm prelabor rupture of membranes.

    Keywords:maternal sars-cov-2 infection; prematurity

    Copyright © The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Journal of maternal-fetal & neonatal medicine

    缩写:J MATERN-FETAL NEO M

    ISSN:1476-7058

    e-ISSN:1476-4954

    IF/分区:1.7/Q4

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Maternal SARS-COV-2 infection and prematurity: the Southern Michigan COVID-19 collaborative